Studies on immunogenicity and protective efficacy of DnaJ of Salmonella Typhi against lethal infection by Salmonella Typhimurium in mice

Vaccine

Volumn 24, Issue 49-50, 2006, Pages 7135-7141

  Sagi, Sarada S K ^a   Paliwal, Piyush ^a   Bansal, Anju ^a   Mishra, Chittaranjan ^a   Khan, Nadeem ^a   Mustoori, Sai Ram ^a   Ilavazhagan, G ^a   Sawhney, R C ^a   Banerjee, P K ^a  

^a DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

Author keywords

DnaJ; HSP; S. Typhi; Vaccine

Indexed keywords

GAMMA INTERFERON; GENOMIC DNA; INTERLEUKIN 2; INTERLEUKIN 4; NICKEL; NITRILOTRIACETIC ACID; PROTEIN DNAJ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; EXPRESSION VECTOR; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; TYPHOID FEVER;

ANIMALS; BACTERIAL VACCINES; CELL PROLIFERATION; CLONING, MOLECULAR; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTES; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALMONELLA INFECTIONS; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; VACCINES, DNA; VACCINES, SYNTHETIC;

EID: 33846233469     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.06.056     Document Type: Article

References (41)

1. Ivanoff B., Levine M.M., and Lambert P.H. Vaccination against fever: present status. Bull World Health Organ 72 (1994) 957-971
2. Kabra S.K. Multidrug resistant typhoid fever. Trop Doct 30 (2000) 195-197
3. WHO position paper. Typhoid vaccines. Weekly epidemiological record 2000;75:257-64.
4. Faucher S.P., Curtiss R., and Daigle F. Selective capture of Salmonella enterica serovar Typhi genes expressed in macrophages that are absent from the Salmonella enterica serovar Typhimurium genome. Infect Immun 73 (2005) 5217-5221
5. Tarr P.E., Kuppens L., Jones T.C., Ivanoff B., Aparin P.G., and Hey Mann D.L. Considerations regarding mass vaccination against typhoid fever as an adjuvant to sanitation and public health measures: potential use in an epidemic in Tajikistan. Am J Trop Med Hyg 61 (1999) 163-170
6. Ashcroft M.T., Singh B., Nicholson C.C., Ritchie J.M., Sorbryan E., and Williams F.A. Seven year field trail of two typhoid vaccines in Guyana. Lancet 2 (1967) 1056-1059
7. Evjetanovic B. Typhoid fever and its prevention. Public Health Rev 2 (1973) 229-246
8. Germanier R. Development of a new oral attenuated typhoid vaccine. Bacterial vaccines, vol. 4. New York, USA; 1982. p. 419-21.
9. Hornick R.C., Woodward T.E., Mc Crumb F.R., Synder M.J., Dawkins A.T., Bulkeley, et al. Typhoid fever vaccine-yes or no?. Med Clin North Am 51 (1967) 617-623
10. Yang H.H., Wu C.G., Xie G.Z., et al. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in South Western China. Bull World Health Organ 79 (2001) 625-631
11. Robbins J.B., and Schneerson R. Polysaccharide protein conjugates: a new generation of vaccines. J Infect Dis 161 (1990) 821-832
12. Levine M.M., Dupant H.L., Gilman R.H., and Libonati J.P. Attenuated streptomycin dependent Salmonella Typhi oral vaccine: potential deleterious effects of lyophilization. J Infect Dis 133 (1976) 424-429
13. Osborn M.J., and Wu H.C. Proteins of the outer membrane of gram negative bacteria. Annu Rev Microbiol 34 (1980) 369-422
14. Chibber S., and Bhardwaj S.B. Protection in mouse peritonitis model mediated by iron-regulated outer membrane protein of Salmonella Typhi coupled to its Vi antigen. J Med Microbiol 53 (2004) 705-709
15. Singh M., Ganguly N.K., Kumar L., and Vohra H. Protective efficacy and immunogenicity of Vi-porin conjugate against Salmonella Typhi. Microbiol Immunol 43 (1999) 535-542
16. Barrios C., Lussow A.R., Van Embden J., Vander Zee R., Rappuoli R., Constantino P., et al. Mycobacterial heat shock proteins as carrier molecules: the use of the 70 kDa mycobacterial heat shock proteins as carrier molecules for conjugate vaccines circumvent the need for adjutants and Bacillus Calmette Guerin priming. Eur J Immunol 22 (1992) 1365-1372
17. Harvey B. News: heat shock proteins often called stress proteins, Hsps have evolved from biological curiosity to potential therapy. Scientist 14 (2000) 16
18. Hendrick J.P., and Harti F. Molecular chaperone functions of Hsps. Annu Rev Biochem 62 (1993) 349-384
19. Zugel U., and Kaufmann S.H.E. Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 12 (1999) 19-39
20. Gething M.J., and Sambrook J.P. Protein folding in the cell. Nature 355 (1992) 35-45
21. Graham A.P. Heat shock proteins in health and disease: therapeutic targets or therapeutic agents. Exp Rev Mol Med 21 (2001) 1-13
22. Kaufmann S.H.E. Heat shock proteins and immune response. Immunol Today 11 (1990) 129-136
23. Young D.B., Lathringa R.B., Hendrix R.W., and Young R.A. Stress proteins are immune targets in leprosy and tuberculosis. Proc Natl Acad Sci 85 (1988) 4267-4270
24. Barrios C., Tongne C., Polla B.S., Lambert P.H., and Del Duidice G. Specificity of antibodies induced after immunization of mice with the mycobacterial heat shock proteins of 65 kDa. Clin Exp Immunol 98 (1994) 224-228
25. Ferrero R.L., Thilberg J.M., Kansau I., Wuscher N., Huerre M., and Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci USA 92 (1995) 6499-6503
26. Francisco J.G., Gomes A.M., George S., and Deepe J.R. An 80 kDa antigen from Histoplasma capsulatum that has homology to heat shock protein 70 induces cell mediated immune responses and protection in mice. Infect Immun 60 (1992) 2565-2571
27. Vania L., Bonato D., Lima V.M.F., Ricar do E., Tascan R.E., Lowrie D.B., et al. Identification and characterization of protective T cells in hsp 65, DNA-vaccinated and Mycobacterium tuberculosis infected mice. Infect Immun 66 (1998) 169-175
28. Lowry O.H., Rough R.N.J., and Randall R.J. Protein measurement with foline phenol reagent. J Biol Chem 193 (1951) 265-275
29. Babich H., and Borefreund. Application of the neutral red cytotoxicity assay to in vitro toxicology. Review. Altern Lab Anim 18 (1990) 129-144
30. Germanier R., and Furer E. Isolation and characterization of Salmonella Typhi gal E mutant Ty2a: a candidate strain for a live typhoid vaccine. J Infect Dis 131 (1975) 553-558
31. Cadoz M. Potential and limitations of polysaccharide vaccines in infancy. Vaccine 16 (1998) 1391-1395
32. Szu S.C., Taylor D.N., Trafa A.C., Clements J.D., Shiloach J., Sadoff J.C., et al. Laboratory and preliminary clinical characterization of VI polysaccharide protein conjugate vaccine. Infect Immun 62 (1994) 4440-4444
33. Kossaczka Z., Lin F.Y., Ho V.A., et al. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2 to 4 year old children in Vietnam. Infect Immun 67 (1999) 5806-5810
34. Multhoff G., and Hightower L.E. Cell surface expression of heat shock proteins and the immune response. Cell Stress Chaperones 1 (1996) 167-176
35. Wurttenberger W., Schoel B., Ivanyi J., and Kaufmann S.H.E. Surface expression by mononuclear phagocytes of an epitope shared with mycobacterial heat shock protein 60. Eur J Immunol 21 (1991) 1089-1092
36. Skinner M.A., Buddle B.M., Wedlock D.N., Keen D., Lisle G.W., Tascon R.E., et al. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against Bovine Tuberculosis. Infect Immun 71 (2003) 4901-4907
37. Retzlaff C.Y., Yamamoto P.S., Friedman H.H., and Klein T.W. Bacterial heat shock proteins directly induce cytokine mRNA and IL-1 secretion in macrophages cultures. Infect Immun 62 (1994) 5689-5693
38. Annette N., and Autenrieth I.B. Immunity against Yersinia enterolitica by vaccination with Yersinia HSP60 immunostimulatory complexes or Yersinia HSP 60 plus interluekin-12. Infect Immun 64 (1996) 2955-2961
39. Jones B.D., Ghori N., and Falkow S. Salmonella Typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells by cells of the Peyer's patches. J Exp Med 180 (1994) 15-23
40. Lanata C.F.C., Ridtori C., Jimenezs L., Garcia J., Levine M.M., Black R.E., et al. Vi serology in detection of chronic Salmonella Typhi carriers in an endemic area. Lancet 2 (1983) 441-443
41. Lowrie D.B., Silva C.L., Crltson M.J., Ragno S., and Tascan R.E. Protection against tuberculosis by a plasmid DNA vaccine. Vaccine 15 (1997) 834-838